From cell lines to PDXs: in vivo confirmation of synergistic drug responses identified in leukemia cell line models.

Verbeek TCAI, Vrenken KS, Arentsen-Peters STCJM, van den Hoof E, Pieters R, Stam RW

Open source

DOI
10.1016/j.bneo.2026.100230
Published
2026 Aug
Container
Blood neoplasia
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bneo.2026.100230,
  title = {From cell lines to PDXs: in vivo confirmation of synergistic drug responses identified in leukemia cell line models.},
  author = {Verbeek TCAI and Vrenken KS and Arentsen-Peters STCJM and van den Hoof E and Pieters R and Stam RW},
  year = {2026},
  journal = {Blood neoplasia},
  doi = {10.1016/j.bneo.2026.100230},
  url = {https://doi.org/10.1016/j.bneo.2026.100230}
}

RIS

TY  - JOUR
TI  - From cell lines to PDXs: in vivo confirmation of synergistic drug responses identified in leukemia cell line models.
AU  - Verbeek TCAI
AU  - Vrenken KS
AU  - Arentsen-Peters STCJM
AU  - van den Hoof E
AU  - Pieters R
AU  - Stam RW
PY  - 2026
JO  - Blood neoplasia
DO  - 10.1016/j.bneo.2026.100230
UR  - https://doi.org/10.1016/j.bneo.2026.100230
ER  - 

APA

TCAI, V., KS, V., STCJM, A., E, V. D. H., R, P., & RW, S. (2026). From cell lines to PDXs: in vivo confirmation of synergistic drug responses identified in leukemia cell line models.. Blood neoplasia. https://doi.org/10.1016/j.bneo.2026.100230

Source records